KGK Insights Blog
WEBINAR: Regulatory Considerations for Probiotic Path-to-Market
Tuesday, January 28, 2020 | (Tuesday) 1pm EST (10am PST) - Join KGK Science for this free webinar exploring the regulatory considerations for efficiently navigating the regulatory landscape to bring a new probiotic to market.
4th Annual IPA Probiotics Workshop: Q&A with KGK CEO Najla Guthrie and George Paraskevakos of IPA
As the title sponsor for the 4th Annual IPA Probiotics Workshop in DC, KGK Science President & CEO, Najla Guthrie got together with IPA Executive Director, George Paraskevakos for a Q&A to discuss the days events.
Are Your Cannabis Edibles Set Up for Sweet Success?
With the new regulations and guidelines surrounding cannabis edibles, it can be difficult to know exactly how to formulate, package, and test them to ensure successful market entry and customer satisfaction. KGK Science can help.
KGK Goes Big on Scientific and Regulatory Expertise at NPA’s The Big Natural Show
Crucial conversations took place at NPA's The Big Natural and Natural Products Day in Washington, D.C., including advocacy for safety and increased regulation.
The 2018 Farm Bill and the Legality of CBD in the United States
The 2018 Farm Bill was passed on December 20, 2018, and initiated a paradigm shift in the way that hemp and its derivatives are viewed in the US.
I’d Like to Conduct Research on My Product. What Now?
Although conducting a clinical trial may seem like a daunting and expensive task, it’s an important investment that will have a substantial return in the product’s life-cycle.
Shifting Paradigms: Discussing the State of Global Health Care with Dr. Mal Evans
Dr. Mal Evans, our CSO, recently spoke at a symposium for the Munk School of Global Affairs & Public Policy. Prospects for Japan’s G20 Osaka Summit provided a critical assessment of the agenda for the upcoming G20 event.
Budding Research: Conducting Clinical Cannabis Trials in Canada
While Canada itself is a wonderful environment in which to study cannabis, KGK takes it one step further.
Is the Industry’s Insight into CBD Half-Baked?
This month, as part of the “early stages” of its establishment of regulatory guidelines for Cannabidiol (CBD), the US Food and Drug Administration (FDA) held its first-ever public hearing on the subject.
What’s Coming Down the Pipe for Cannabis Research?
As our pursuit of cannabis knowledge continues to hasten, a large crop of innovative and interesting studies are sure to arise. But what should this novel research explore? How can we improve our investigative processes?
Get the Scoop on Synbiotics
It’s no secret that dietary fibre and probiotics are both vital in the enhancement and maintenance of a healthy digestive system. However, the power they hold when united is lesser understood: together, they may greatly improve gut function.
Regulatory Developments in the Cannabiz
An update on the evolving rules and regulations surrounding cannabis in Canada and the U.S.